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to detect the virus and determine the 
amount of the viral RNA in the me-
dium. Cells and supernatants of the 3 
passages were virus positive, and the 
control inoculated with phosphate-
buffered saline was virus negative. 
However, with each passage, the 
amount of viral RNA in the medium 
decreased. Whether the positive result 
was caused by residual viruses of the 
initial inoculation or by the decreased 
propagation of the virus in the cells is 
not clear. Further studies, such as con-
tinuous serial passages and neutraliza-
tion assay, are needed to determine the 
ﬁ  nal activity of the virus in RD cells, 
as well as in other cells such as Vero 
and HeLa, because several species of 
picornaviruses have been identiﬁ  ed as 
causing persistent infections in these 
cells in vitro (6–10).
In conclusion, we report the ge-
netic characterization and biological 
properties of a new agent in China. 
Of note, while we were preparing this 
article, a similar article from Hungary 
was published (5). After comparing our 
1,185-bp sequence with the sequence 
from Hungary, we found that our se-
quence was 171 bp longer at the 3′ end 
and 50 bp shorter at the 5′ end and that 
the truncated sequence in the middle 
(same length) had a nucleotide homol-
ogy of 92.1%. Phylogenetic analysis 
indicated that the 2 sequences may 
share the same origin (Figure, panel 
B). In addition, prevalence of our virus 
(30.12%) was higher than that of the 
virus from Hungary (13.3%). Further 
studies are needed to determine the 
complete genome and the relevance of 
the candidate porcine Kobuvirus as a 
causative agent of disease in pigs and 
a potential zoonotic agent. 
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Postoperative 
Panophthalmitis 
Caused by Whipple 
Disease 
To the Editor: The clinical spec-
trum of Whipple disease has widely ex-
panded since its etiologic agent, Troph-
eryma whipplei, was isolated in 2000 
(1). Systematic 16S rDNA sequencing 
unexpectedly identiﬁ  ed T. whipplei in 
patients for whom blood cultures were 
negative for endocarditis, spondyli-
tis, and uveitis (2). Features common 
to these conditions and to Whipple 
disease include long-standing, unex-
plained arthralgia and deterioration of 
the patient’s condition after treatment 
with immunosuppressive drugs (2). 
We report an unexpected case of post-
operative panendophthalmitis identi-
ﬁ  ed by systematic 16S rDNA sequenc-
ing of a vitreous sample in a patient 
who had unexplained arthralgia and 
had been given topical corticosteroids 
after cataract surgery.
A 78-year-old woman in France 
underwent left eye phacoemulsiﬁ  ca-
tion with intraocular lens implantation 
in May 2005 and retinal surgery fol-
lowed by local corticoid application 
in April 2006. She had experienced 
cortisone-resistant polyarthralgia for 
2 years before the ﬁ   rst surgery. In 
July 2006, she showed decreased vi-
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sual acuity (20/1,000) and a painful, 
red eye. Chronic postoperative en-
dophthalmitis was suspected, and the 
patient underwent anterior chamber 
paracentesis (ACP). Parameters in-
cluded 0.614 × 109 eosinophils/L in 
the blood and an erythrocyte sedimen-
tation rate of 70 mm in the ﬁ  rst hour. 
Sequencing of 16S rDNA of the 
ACP specimen showed 99.9% similar-
ity with that of T. whipplei (GenBank 
accession no. AJ551273). A speciﬁ  c 
PCR conﬁ  rmed this result in the ocular 
sample and detected T. whipplei in sa-
liva and stool samples, whereas blood 
and cerebrospinal ﬂ  uid were negative 
for the organism by PCR. Duodenal 
biopsy specimens were negative by 
periodic acid–Schiff staining, spe-
ciﬁ   c immunohistochemical analysis, 
and PCR.
The patient was treated with topi-
cal corticosteroids, cycloplegic drugs, 
doxycycline (200 mg/d), hydroxy-
chloroquine (200 mg 3×/d), and sul-
famethoxazole/trimethoprim (1,600 
mg and 320 mg 3×/d) (2). She was 
hospitalized for 7 days in the ophthal-
mology department and for 4 days in 
the infectious disease department. At 
8-month follow-up, visual acuity had 
improved (20/50) despite intraocular 
inﬂ   ammation with a Tyndall effect, 
moderate capsular opaciﬁ  cation,  de-
creased vitreitis, macular edema, and 
retinal macular abnormalities shown 
by optical coherence tomography. T. 
whipplei DNA was again not detected 
by PCR in saliva and stool samples 
at 8-month follow-up, and the patient 
remained free of symptoms at 16-
month follow-up when treatment was 
stopped.
Diagnosis of Whipple disease 
uveitis was conﬁ  rmed by detection of 
T. whipplei DNA in the ocular sample 
by 2 laboratories that used 2 molecu-
lar targets and negative controls. T. 
whipplei was identiﬁ  ed by 16S rDNA 
sequencing and by detection of T. 
whipplei–speciﬁ   c repeat sequences. 
Further investigations detected T. 
whipplei in saliva and stool samples. 
Uveitis was the initial manifestation 
of Whipple disease, although patient 
evaluation showed a 2-year history 
of idiopathic, corticoresistant pol-
yarthralgia described as a hallmark 
of Whipple disease (2). Initial unex-
plained eosinophilia in blood was ob-
served, as in several conﬁ  rmed cases 
of Whipple disease (2).
Uveitis has been reported in Whip-
ple disease (2), but <20 patients had 
T. whipplei in a diseased eye (Table). 
T. whipplei has been found by peri-
odic acid–Schiff staining of foamy 
macrophages, electron microscopy, 
and immunocytochemical detection 
in ocular monocytes (3–10). Detec-
tion of T. whipplei DNA (6–10) has 
been conﬁ  rmed by sequencing in only 
2 patients, including the case reported 
herein.
Diagnosis of T. whipplei uveitis 
in our patient was made 3 months after 
ocular surgery. The patient’s condition 
was diagnosed as chronic postopera-
tive panendophthalmitis, which raised 
the issue of nosocomial transmission 
of  T.  whipplei. We have reported a 
correlation between diagnosis of T. 
whipplei uveitis and a history of ocular 
surgery (7). By reanalyzing detailed 
published reports, we found that 11 of 
19 patients with intraocular demon-
stration of T. whipplei had a history of 
ocular surgery before documentation 
of Whipple disease uveitis (Table). T. 
whipplei has not been reported as be-
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Table. Characteristics of 19 patients with Whipple disease uveitis documented by presence of Tropheryma whipplei in a diseased eye* 
Patient.
no. Age, y/sex  Class Location
Postoperative
uveitis
Use of local or 
systemic steroids 
Microscopy, 
PAS stain  EM PCR Reference
1 52/M I B – No + + ND (3)
2 60/M A B – No + + ND (5)
3 56/M A B + Yes + ND ND (4)
4 47/M A B – Yes + ND ND (4)
5 65/M A B + Yes + + + (6)
6 59/F A B + Yes + + + (7)†
7 53/F Pa U – Yes + ND + (7)†
8 65/M I U + Yes + ND + (7)†
9 NR/NR NR NR NR NR ND ND + (8)
10 65/M I U + Yes ND ND +‡ (7)
11 81/M P U + Yes ND ND +‡ (7)
12 35/M P U NR NR ND ND +‡ (7)
13 46/M P U – No ND ND +‡ (7)
14 3/F A U – No ND ND +‡ (7)
15 90/F A U + Yes ND ND +‡ (7)
16 69/M P U + Yes ND ND +‡ (7)
17 20/F A U + Yes ND ND +‡ (7)
18 74/F Pa U + Yes ND ND +‡ (7)
19 78/F P U + Yes ND ND +‡ (7)
*PAS, periodic acid–Schiff; EM, electron microscopy; I, intermediate; B, bilateral; ND, not done; A, anterior; Pa, panuveitis; U, unilateral; NR, not reported; 
P, posterior.    
†Reviewed by Drancourt et al. (7). 
‡These patients were considered to have suspected cases. LETTERS
ing responsible for nosocomial infec-
tion. Items used during the patient’s 
ocular surgery were conﬁ  rmed to be 
disposable and nonreused.
Topical drops of corticosteroids 
commonly applied during cataract 
surgery for intraocular lens implanta-
tion penetrate ocular structures. An 
alternative hypothesis is that corticos-
teroids applied during ocular surgery 
reactivate a latent ocular infection. 
Our review indicated that 13 of 19 
patients with documented T. whipplei 
uveitis had received topical or system-
ic corticosteroids before the diagnosis 
(Table) (7). Worsening of Whipple 
disease has been reported in patients 
receiving corticoid therapy for arthral-
gia (10). We speculate that our patient 
had an asymptomatic ocular infection 
before surgery.
This case shows that ocular sur-
gery and use of topical corticosteroids 
that penetrate ocular structures could 
reactivate a latent T. whipplei ocular 
infection. We suggest that patients 
with postoperative panendophthalmi-
tis be tested for T. whipplei by PCR.
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Klebsiella 
pneumoniae 
Carbapenemase, 
Canada
To the Editor: Carbapenems are 
used to treat life-threatening infections 
caused by extremely drug-resistant 
gram-negative pathogens; these drugs 
represent the last line of defense in the 
antimicrobial drug armamentarium 
against serious or invasive infection 
(1). The rapid global spread of Kleb-
siella pneumoniae that produces K. 
pneumoniae carbapenemase (KPC), 
especially in the northeastern United 
States (e.g., New York state), is of ma-
jor concern (2,3). KPC β-lactamases 
belong to the family of serine car-
bapenemases and are usually found 
in  K. pneumoniae and Escherichia 
coli. KPC hydrolyzes β-lactam agents, 
thereby reducing their action. KPC 
activity has been reported, albeit less 
frequently, in other family Enterobac-
teriaceae ( K. oxytoca,  Enterobacter 
spp., Salmonella spp., Citrobacter fre-
undii, and Serratia spp.) as well as in 
Pseudomonas aeruginosa (1).
The blaKPC genes have been identi-
ﬁ  ed on conjugative plasmids and pose 
an infection control problem because 
plasmids could theoretically be trans-
mitted from one species to another (4). 
The few therapeutic options for treat-
ing infections caused by organisms 
containing these β-lactamases are 
aminoglycosides, glycylcyclines, pol-
ymyxins, or combinations (1). A ma-
jor concern is that routine susceptibil-
ity testing methods based on existing 
breakpoints can falsely identify KPC 
producers as susceptible to carbapen-
ems. Such results pose the potential 
risk for increased illness and death, 
longer hospital stays, and nosocomial 
spread of infection.
In 2008, the Public Health Labo-
ratory in Toronto received clinical iso-
lates of K. pneumoniae from urine and 
sputum of 1 patient. The hospital labo-
ratory had forwarded the isolates to the 
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